Nilvadipine is a dihydropyridine calcium channel blocker primarily used in the treatment of hypertension and chronic major cerebral artery occlusion. This category contains essential reference standards… Read more
Nilvadipine is a dihydropyridine calcium channel blocker primarily used in the treatment of hypertension and chronic major cerebral artery occlusion. This category contains essential reference standards for nilvadipine API, as well as a range of related compounds required for rigorous pharmaceutical analysis. Laboratory professionals utilize these high-quality impurities to facilitate accurate impurity profiling, supporting the development and validation of analytical methods to ensure regulatory compliance. The inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, provides necessary internal standards for mass spectrometry-based assays, enabling precise quantification of the drug and its metabolites in complex matrices. By providing access to these specialized reference materials, analytical testing and quality control protocols can be maintained with the high levels of precision required for safety and efficacy assessments in pharmaceutical manufacturing and research environments.